Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Wieser, Martina ^a   Sauerland, Stefan ^c   Arnold, Dirk ^d   Schmiegel, Wolff ^a,b   Reinacher Schick, Anke ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; DIARRHEA; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG FEVER; FOLLOW UP; HUMAN; LEUKOPENIA; LIVER METASTASIS; LIVER TOXICITY; META ANALYSIS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PERIOPERATIVE CHEMOTHERAPY; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK REDUCTION; SENSORY NEUROPATHY; STOMATITIS; SURVIVAL TIME; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; COLORECTAL TUMOR; LIVER TUMOR; META ANALYSIS (TOPIC); METASTASIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77953662328     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-309     Document Type: Article

References (27)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005, 16(3):481-488. 10.1093/annonc/mdi098, 15718248.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA: a cancer journal for clinicians 2009, 59(4):225-249. 10.3322/caac.20006, 19474385.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: a cancer journal for clinicians 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
4. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. The New England journal of medicine 1999, 341(27):2039-2048. 10.1056/NEJM199912303412702, 10615075.
5. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007, 25(29):4575-4580. 10.1200/JCO.2007.11.0833, 17925551.
6. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF. Liver resection for colorectal metastases. J Clin Oncol 1997, 15(3):938-946.
7. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Annals of surgical oncology 2001, 8(4):347-353. 10.1007/s10434-001-0347-3, 11352309.
8. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996, 77(7):1254-1262. 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I, 8608500.
9. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol 2002, 20(6):1499-1505. 10.1200/JCO.20.6.1499, 11896097.
10. Lygidakis NJ, Ziras N, Parissis J. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepato-gastroenterology 1995, 42(2):155-161.
11. Lorenz M, Muller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Annals of surgery 1998, 228(6):756-762. 10.1097/00000658-199812000-00006, 1191593, 9860474.
12. Rudroff C, Altendorf-Hoffmann A, Stangl R, Scheele J. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie 1999, 384(3):243-249.
13. Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990, 8(11):1885-1893.
14. Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D, Nitti D, Torri V, Elias D, O'Callaghan C, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008, 26(30):4906-4911. 10.1200/JCO.2008.17.3781, 18794541.
15. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008, 371(9617):1007-1016. 10.1016/S0140-6736(08)60455-9, 2277487, 18358928.
16. Sampson M, Barrowman NJ, Moher D, Klassen TP, Pham B, Platt R, St John PD, Viola R, Raina P. Should meta-analysts search Embase in addition to Medline?. Journal of clinical epidemiology 2003, 56(10):943-955. 10.1016/S0895-4356(03)00110-0, 14568625.
17. Langer Bernhard HB, Labianca R, Shepherd L, Nitti D, Marsoni S, Tu D, Sargeant A, Fields A, . University of Toronto, Toronto, ON, Canada; Institute Jules Bordet, Brussels, Belgium; Ospedali Riuniti, Bergamo, Italy; NCIC CTG, Queens University, Kingston, ON, Canada; University of Padova, Padova, Italy; South Europe New Drugs Organization, Milan, Italy; Cross Cancer Inst, Edmonton, AB, Canada Fluorouracil (FU) plus l-leucovorin (l-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. Proc Am Soc Clin Oncol 2002, 21. (abstr 592), University of Toronto, Toronto, ON, Canada; Institute Jules Bordet, Brussels, Belgium; Ospedali Riuniti, Bergamo, Italy; NCIC CTG, Queens University, Kingston, ON, Canada; University of Padova, Padova, Italy; South Europe New Drugs Organization, Milan, Italy; Cross Cancer Inst, Edmonton, AB, Canada.
18. Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C, Shacham-Shmueli E, Rivera F, Kwok-Keung Choi C, Santoro A. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 2009, 20(12):1964-1970. 10.1093/annonc/mdp236, 19567451.
19. Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 2000, 88(7):1549-1556. 10.1002/(SICI)1097-0142(20000401)88:7<1549::AID-CNCR8>3.0.CO;2-K, 10738212.
20. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006, 24(31):4976-4982. 10.1200/JCO.2006.06.8353, 17075115.
21. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in medicine 1998, 17(24):2815-2834. 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8, 9921604.
22. Messori A TS, Vaiani M, et al. Survival meta-analysis of individual patient data and survial meta-analysis of published (aggregate) data: Is ther an intermediate approach between these two opposite options?. Clin Drug Invest 2000, 20:309-316.
23. Lopez-Ladron AJS, Bernabe R, Bernardos A, Arriola E, Serrano J, Reina JJ, Gomez MA, Barneto I, Moreno-Nogueira JA, . Hospital Virgen Rocio, Sevilla, Spain; Hospital JR Jimenez, Huelva, Spain; Hospital Reina Sofia, Cordoba, Spain Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer. Proc Am Soc Clin Oncol 2003, 22. (abstr 1497), Hospital Virgen Rocio, Sevilla, Spain; Hospital JR Jimenez, Huelva, Spain; Hospital Reina Sofia, Cordoba, Spain.
24. Asahara T, Kikkawa M, Okajima M, Ojima Y, Toyota K, Nakahara H, Katayama K, Itamoto T, Marubayashi S, One E, et al. Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepato-gastroenterology 1998, 45(21):805-811.
25. Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, Doroshow J, Ganteaume L, Hill RL, Kokal WA, Riihimaki DU, et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 1986, 57(3):492-498. 10.1002/1097-0142(19860201)57:3<492::AID-CNCR2820570315>3.0.CO;2-M, 2935243.
26. Kokudo N, Hasegawa K, Makuuchi M. Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases. J Clin Oncol 2007, 25(10):1299-1300. author reply 1300, 10.1200/JCO.2006.09.9069, 17401028.
27. Nelson R, Freels S. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane database of systematic reviews (Online) 2006, (4):CD003770.